These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 381947)

  • 1. The action of the dihydro derivatives of prostacyclin--(6R)-PGI1 and (6S)-PGI1 on the heart and the coronary vasculature.
    Schrör K
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):213-7. PubMed ID: 381947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostacyclin on coronary circulation, heart rate and myocardial contractile force in isolated hearts of guinea pig and rabbit - comparison with prostaglandin E2.
    Schrör K; Moncada S
    Prostaglandins; 1979 Mar; 17(3):367-73. PubMed ID: 382264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig.
    Dusting GJ; Moncada S; Vane JR
    Eur J Pharmacol; 1977 Oct; 45(3):301-4. PubMed ID: 336382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and electrophysiological analysis of a selective vasodilatory prostacyclin analogue, 5-nitro-PGI1.
    Kecskeméti V; Stadler I; Körmöczy P
    Biomed Biochim Acta; 1984; 43(8-9):S287-90. PubMed ID: 6440542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
    Schrör K; Moncada S; Ubatuba FB; Vane JR
    Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin-induced coronary vasodilation. Interactions with adenosine, cyclic AMP and energy charge in the rat heart in vitro.
    Schrör K; Link HB; Rösen R; Klaus W; Rösen P
    Eur J Pharmacol; 1980 Jun; 64(4):341-8. PubMed ID: 6156077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity of prostaglandin E2 (PGE2) in reducing coronary vascular resistance: A comparison with adenosine.
    Schrör K; Berg-Becker M; Nookhwun C
    Basic Res Cardiol; 1978; 73(3):287-97. PubMed ID: 687323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of increased prostaglandins and prostacyclin for the effect of oxyfedrin in isolated guinea pig heart preparations].
    Mentz P; Förster W
    Arzneimittelforschung; 1984; 34(12):1739-42. PubMed ID: 6397198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.
    Schrör K; Rösen P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jan; 306(1):101-3. PubMed ID: 218118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac effects of prostaglandins and their modification by the prostaglandin antagonist N-0164.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1980 Jul; 214(1):45-9. PubMed ID: 6993659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of isoprenaline and prostaglandin E2 with respect to myocardial contractile force, coronary vascular resistance and myocardial oxygen consumption in guinea-pig isolated hearts.
    Krebs R; Schrör K
    Br J Pharmacol; 1976 Aug; 57(4):533-41. PubMed ID: 963342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the coronary vascular resistance by indomethacin in the isolated guinea pig heart preparation in the absence of changes in mechanical performance and oxygen consumption.
    Schrör K; Krebs R; Nookhwun C
    Eur J Pharmacol; 1976 Sep; 39(1):161-9. PubMed ID: 964300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
    Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
    Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.